Drug delivery CDMO earmarks $356M to expand injectable device capacity

Anna Brown

News Reporter

PCI Pharma Services is pouring $365 million to expand its US and Irish footprint for commercial and clinical packaging of drug-device products to meet evolving …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Drug delivery CDMO earmarks $356M to expand injectable device capacity

Anna Brown

News Reporter

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Updated: Gene therapy maker bluebird bio cuts costs again, lays off staff

Biogen, UCB declare Phase 3 lupus win and prep a second trial, but details are scant

Wave rides new Phase 2 DMD data as it sets sights on accelerated approval

Sanofi hires Mike Quigley as next chief scientist, internal memo says

Flagship’s AI biotech Generate lands $65M upfront in Novartis deal, as first clinical readouts near

PDCs vs. ADCs: A New Frontier in Targeted Cancer Therapies and the Potential for Development Partnerships

Drug de­liv­ery CD­MO ear­marks $356M to ex­pand in­jectable de­vice ca­pac­i­ty

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Drug delivery CDMO earmarks $356M to expand injectable device capacity